Hepatic reduction of the secondary bile acid 7-oxolithocholic acid is mediated by 11β-hydroxysteroid dehydrogenase 1

Contribution of Fructose-6-Phosphate to Glucocorticoid Activation in the Endoplasmic Reticulum: Possible Implication in the Metabolic Syndrome

(2010) Silvia Senesi et al.   ENDOCRINOLOGY

The glucocorticoid-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 has broad substrate specificity: Physiological and toxicological considerations

(2010) Alex Odermatt et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease

(2009) Patrick W.F. Hadoke et al.   BRITISH JOURNAL OF PHARMACOLOGY

11β-hydroxysteroid dehydrogenase type 1 inhibitors: a review of recent patents

(2009) Craig D Boyle et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Conversion of cholic acid and chenodeoxycholic acid into their 7-oxo derivatives byBacteroides intestinalisAM-1 isolated from human feces

(2009) Satoru Fukiya et al.   FEMS MICROBIOLOGY LETTERS

Inhibition of 11β-hydroxysteroid dehydrogenase type 1 by plant extracts used as traditional antidiabetic medicines

(2009) Christel Gumy et al.   FITOTERAPIA

Bile Acids: Chemistry, Pathochemistry, Biology, Pathobiology, and Therapeutics

(2008) A. F. Hofmann et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

11-Beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors in Type 2 diabetes mellitus and obesity

(2008) Katherine A Hughes et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

11β-Hydroxysteroid dehydrogenase 1 reductase activity is dependent on a high ratio of NADPH/NADP+ and is stimulated by extracellular glucose

(2008) Anna A. Dzyakanchuk et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Hexose-6-Phosphate Dehydrogenase and 11β-Hydroxysteroid Dehydrogenase-1 Tissue Distribution in the Rat

(2007) Elise P. Gomez-Sanchez et al.   ENDOCRINOLOGY